Polyphor AG / Key word(s): Study results28-Jun-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Allschwil, Switzerland, June 28, 2021Polyphor provides update on the Phase III FORTRESS study of balixafortide in patients...